Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9D6Y9

Entry ID Method Resolution Chain Position Source
AF-Q9D6Y9-F1 Predicted AlphaFoldDB

34 variants for Q9D6Y9

Variant ID(s) Position Change Description Diseaes Association Provenance
rs265003638 10 G>E No EVA
rs221292929 14 P>L No EVA
rs229232227 131 N>S No EVA
rs3389336865 133 S>P No EVA
rs214562831 135 L>P No EVA
rs251789732 145 V>F No EVA
rs13459309 177 H>Q No EVA
rs3407179514 224 L>P No EVA
rs3389422823 247 A>T No EVA
rs3407058392 268 E>G No EVA
rs3389439423 272 L>F No EVA
rs3389433695 276 A>G No EVA
rs13459310 318 T>I No EVA
rs3389336901 410 I>L No EVA
rs3389381949 437 M>K No EVA
rs3389391565 452 D>E No EVA
rs3389433685 506 L>M No EVA
rs3389371946 507 A>P No EVA
rs3389426230 508 P>H No EVA
rs3389403289 509 F>I No EVA
rs3389422355 510 T>P No EVA
rs3389391439 517 I>L No EVA
rs3389433719 547 E>G No EVA
rs3389420633 589 R>S No EVA
rs3389417418 622 L>I No EVA
rs253234232 645 K>N No EVA
rs3413052178 667 T>I No EVA
rs13459311 668 N>D No EVA
rs3389417349 670 F>S No EVA
rs3389420708 693 L>P No EVA
rs3389412462 694 I>T No EVA
rs3389429565 697 N>S No EVA
rs3389391521 701 Q>R No EVA
rs3389426171 702 N>D No EVA

No associated diseases with Q9D6Y9

3 regional properties for Q9D6Y9

Type Name Position InterPro Accession
domain Glycoside hydrolase, family 13, N-terminal 76 - 161 IPR004193
domain Glycosyl hydrolase, family 13, catalytic domain 221 - 568 IPR006047
domain Alpha-amylase/branching enzyme, C-terminal all beta 603 - 697 IPR006048

Functions

Description
EC Number 2.4.1.18 Hexosyltransferases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.

5 GO annotations of molecular function

Name Definition
1,4-alpha-glucan branching enzyme activity Catalysis of the transfer of a segment of a (1->4)-alpha-D-glucan chain to a primary hydroxyl group in a similar glucan chain.
1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) Catalysis of the reaction: a glucosylated glycogenin = a glycogen.
carbohydrate binding Binding to a carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates.
cation binding Binding to a cation, a charged atom or group of atoms with a net positive charge.
hydrolase activity, hydrolyzing O-glycosyl compounds Catalysis of the hydrolysis of any O-glycosyl bond.

3 GO annotations of biological process

Name Definition
carbohydrate metabolic process The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.
glycogen biosynthetic process The chemical reactions and pathways resulting in the formation of glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues.
negative regulation of neuron apoptotic process Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q6T308 GBE1 1,4-alpha-glucan-branching enzyme Felis catus (Cat) (Felis silvestris catus) PR
Q6EAS5 GBE1 1,4-alpha-glucan-branching enzyme Equus caballus (Horse) PR
Q04446 GBE1 1,4-alpha-glucan-branching enzyme Homo sapiens (Human) PR
10 20 30 40 50 60
MAAPAAPAAG ETGPDARLEA ALADVPELAR LLEIDPYLKP FAADFQRRYK KFSQVLHDIG
70 80 90 100 110 120
ENEGGIDKFS RGYESFGIHR CSDGGIYCKE WAPGAEGVFL TGEFSGWNPF SHPYKKLEYG
130 140 150 160 170 180
KWELYIPPKQ NKSPLIPHGS KLKVVITSKS GEILYRISPW AKYVVRENNN VNYDWIHWAP
190 200 210 220 230 240
EDPYKFKHSR PKKPRSLRIY ESHVGISSHE GKIASYKHFT SNVLPRIKDL GYNCIQLMAI
250 260 270 280 290 300
MEHAYYASFG YQITSFFAAS SRYGTPEELK ELVDTAHSMG IVVLLDVVHS HASKNSEDGL
310 320 330 340 350 360
NMFDGTDSCY FHSGPRGTHD LWDSRLFIYS SWEVLRFLLS NIRWWLEEYC FDGFRFDGVT
370 380 390 400 410 420
SMLYHHHGMG QGFSGDYNEY FGLQVDEDAL IYLMLANHLA HTLYPDSITI AEDVSGMPAL
430 440 450 460 470 480
CSPTSQGGGG FDYRLAMAIP DKWIQLLKEF KDEDWNMGNI VYTLTNRRYL EKCVAYAESH
490 500 510 520 530 540
DQALVGDKTL AFWLMDAEMY TNMSVLAPFT PVIDRGIQLH KMIRLITHGL GGEGYLNFMG
550 560 570 580 590 600
NEFGHPEWLD FPRKGNNESY HYARRQFNLT DDDLLRYKFL NNFDRDMNRL EERCGWLSAP
610 620 630 640 650 660
QAYVSEKHEA NKTITFERAG LLFIFNFHPS KSYTDYRVGT ATPGKFKIVL DSDAAEYGGH
670 680 690 700
QRLDHNTNYF AEAFEHNGRP YSLLVYIPSR VALILQNVDL QN